What is the current Price Target for the TG Therapeutics, Inc. stock?

The average TG Therapeutics, Inc. target price is $46.92. This is 77.79% higher than the current stock price. The highest price target is 118.83%, the lowest is -57.90%. 10 Analysts have issued a price target TG Therapeutics, Inc. 2026 .

How high will the TG Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the TG Therapeutics, Inc. stock will rise. The performance of stocks, including the TG Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the TG Therapeutics, Inc. stock today?

The performance of TG Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the TG Therapeutics, Inc. stock fall?

The decline in TG Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

TG Therapeutics, Inc. Forecast, price target & analysts

$26.50

0.40% today

Nasdaq, Aug 12, 04:19 pm CET

ISIN

US88322Q1085

Symbol

TGTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

TG Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

TG Therapeutics, Inc. Classifications & Recommendation:

Buy

80%

Hold

13%

Sell

TG Therapeutics, Inc. Price Target

Target Price	$46.92
Price	$26.39
Potential	77.79% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target TG Therapeutics, Inc. 2026 . The average TG Therapeutics, Inc. target price is $46.92. This is 77.79% register free of charge higher than the current stock price. The highest price target is $57.75 118.83% register free of charge , the lowest is $11.11 57.90% register free of charge .
	A rating was issued by 15 analysts: 12 Analysts recommend TG Therapeutics, Inc. to buy, 2 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the TG Therapeutics, Inc. stock has an average upside potential 2026 of 77.79% register free of charge . Most analysts recommend the TG Therapeutics, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	329.00	605.38
	40.80%	84.01%
EBITDA Margin	12.77%	24.70%
	43.13%	93.48%

10 Analysts have issued a sales forecast TG Therapeutics, Inc. 2025 . The average TG Therapeutics, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$329m	40.80%
2025	$605m 84.01% Unlock
2026	$843m 39.26% Unlock
2027	$1.0b 23.96% Unlock
2028	$1.4b 36.56% Unlock
2029	$1.7b 15.98% Unlock
2030	$1.8b 8.76% Unlock
2031	$2.1b 18.50% Unlock
2032	$2.4b 11.06% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	0.15	0.79
	66.67%	426.67%
P/E		33.24

10 Analysts have issued a TG Therapeutics, Inc. forecast for earnings per share. The average TG Therapeutics, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$0.15	66.67%
2025	$0.79 426.67% Unlock
2026	$1.76 122.78% Unlock
2027	$2.38 35.23% Unlock
2028	$3.77 58.40% Unlock
2029	$4.29 13.79% Unlock
2030	$4.52 5.36% Unlock

Current	71.32	114.83%
2025	33.24 53.40% Unlock
2026	15.00 54.87% Unlock
2027	11.08 26.13% Unlock
2028	7.00 36.82% Unlock
2029	6.15 12.14% Unlock
2030	5.84 5.04% Unlock

TG Therapeutics, Inc....

Current TG Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 04 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 15 2025
JP Morgan	Locked ➜ Locked	Locked	Nov 25 2024
Goldman Sachs	Locked ➜ Locked	Locked	Nov 05 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 05 2024
TD Cowen	Locked ➜ Locked	Locked	Oct 29 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 18 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 04 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 15 2025
Locked JP Morgan: Locked ➜ Locked	Nov 25 2024
Locked Goldman Sachs: Locked ➜ Locked	Nov 05 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 05 2024
Locked TD Cowen: Locked ➜ Locked	Oct 29 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 18 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 29.77%

Deutsche Telekom 29.37%

BioNTech SE - ADR 28.36%

PayPal 25.45%

Walt Disney 22.35%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now